Index
1 Market Overview of Genome Editing and Genome Engineering
1.1 Genome Editing and Genome Engineering Market Overview
1.1.1 Genome Editing and Genome Engineering Product Scope
1.1.2 Genome Editing and Genome Engineering Market Status and Outlook
1.2 Global Genome Editing and Genome Engineering Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Genome Editing and Genome Engineering Market Size by Region (2018-2029)
1.4 Global Genome Editing and Genome Engineering Historic Market Size by Region (2018-2023)
1.5 Global Genome Editing and Genome Engineering Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Genome Editing and Genome Engineering Market Size (2018-2029)
1.6.1 North America Genome Editing and Genome Engineering Market Size (2018-2029)
1.6.2 Europe Genome Editing and Genome Engineering Market Size (2018-2029)
1.6.3 Asia-Pacific Genome Editing and Genome Engineering Market Size (2018-2029)
1.6.4 Latin America Genome Editing and Genome Engineering Market Size (2018-2029)
1.6.5 Middle East & Africa Genome Editing and Genome Engineering Market Size (2018-2029)
2 Genome Editing and Genome Engineering Market by Type
2.1 Introduction
2.1.1 CRISPR
2.1.2 TALEN
2.1.3 ZFN
2.2 Global Genome Editing and Genome Engineering Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Genome Editing and Genome Engineering Historic Market Size by Type (2018-2023)
2.2.2 Global Genome Editing and Genome Engineering Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Genome Editing and Genome Engineering Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Genome Editing and Genome Engineering Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Genome Editing and Genome Engineering Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Genome Editing and Genome Engineering Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Genome Editing and Genome Engineering Revenue Breakdown by Type (2018-2029)
3 Genome Editing and Genome Engineering Market Overview by Application
3.1 Introduction
3.1.1 Cell Line Engineering
3.1.2 Animal Genetic Engineering
3.1.3 Plant Genetic Engineering
3.1.4 Others
3.2 Global Genome Editing and Genome Engineering Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Genome Editing and Genome Engineering Historic Market Size by Application (2018-2023)
3.2.2 Global Genome Editing and Genome Engineering Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Genome Editing and Genome Engineering Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Genome Editing and Genome Engineering Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Genome Editing and Genome Engineering Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Genome Editing and Genome Engineering Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Genome Editing and Genome Engineering Revenue Breakdown by Application (2018-2029)
4 Genome Editing and Genome Engineering Competition Analysis by Players
4.1 Global Genome Editing and Genome Engineering Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Genome Editing and Genome Engineering as of 2022)
4.3 Date of Key Players Enter into Genome Editing and Genome Engineering Market
4.4 Global Top Players Genome Editing and Genome Engineering Headquarters and Area Served
4.5 Key Players Genome Editing and Genome Engineering Product Solution and Service
4.6 Competitive Status
4.6.1 Genome Editing and Genome Engineering Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Thermo Fisher Scientific
5.1.1 Thermo Fisher Scientific Profile
5.1.2 Thermo Fisher Scientific Main Business
5.1.3 Thermo Fisher Scientific Genome Editing and Genome Engineering Products, Services and Solutions
5.1.4 Thermo Fisher Scientific Genome Editing and Genome Engineering Revenue (US$ Million) & (2018-2023)
5.1.5 Thermo Fisher Scientific Recent Developments
5.2 Merck
5.2.1 Merck Profile
5.2.2 Merck Main Business
5.2.3 Merck Genome Editing and Genome Engineering Products, Services and Solutions
5.2.4 Merck Genome Editing and Genome Engineering Revenue (US$ Million) & (2018-2023)
5.2.5 Merck Recent Developments
5.3 Horizon Discovery
5.3.1 Horizon Discovery Profile
5.3.2 Horizon Discovery Main Business
5.3.3 Horizon Discovery Genome Editing and Genome Engineering Products, Services and Solutions
5.3.4 Horizon Discovery Genome Editing and Genome Engineering Revenue (US$ Million) & (2018-2023)
5.3.5 Genscript Recent Developments
5.4 Genscript
5.4.1 Genscript Profile
5.4.2 Genscript Main Business
5.4.3 Genscript Genome Editing and Genome Engineering Products, Services and Solutions
5.4.4 Genscript Genome Editing and Genome Engineering Revenue (US$ Million) & (2018-2023)
5.4.5 Genscript Recent Developments
5.5 Sangamo Biosciences
5.5.1 Sangamo Biosciences Profile
5.5.2 Sangamo Biosciences Main Business
5.5.3 Sangamo Biosciences Genome Editing and Genome Engineering Products, Services and Solutions
5.5.4 Sangamo Biosciences Genome Editing and Genome Engineering Revenue (US$ Million) & (2018-2023)
5.5.5 Sangamo Biosciences Recent Developments
5.6 Integrated DNA Technologies
5.6.1 Integrated DNA Technologies Profile
5.6.2 Integrated DNA Technologies Main Business
5.6.3 Integrated DNA Technologies Genome Editing and Genome Engineering Products, Services and Solutions
5.6.4 Integrated DNA Technologies Genome Editing and Genome Engineering Revenue (US$ Million) & (2018-2023)
5.6.5 Integrated DNA Technologies Recent Developments
5.7 Lonza
5.7.1 Lonza Profile
5.7.2 Lonza Main Business
5.7.3 Lonza Genome Editing and Genome Engineering Products, Services and Solutions
5.7.4 Lonza Genome Editing and Genome Engineering Revenue (US$ Million) & (2018-2023)
5.7.5 Lonza Recent Developments
5.8 New England Biolabs
5.8.1 New England Biolabs Profile
5.8.2 New England Biolabs Main Business
5.8.3 New England Biolabs Genome Editing and Genome Engineering Products, Services and Solutions
5.8.4 New England Biolabs Genome Editing and Genome Engineering Revenue (US$ Million) & (2018-2023)
5.8.5 New England Biolabs Recent Developments
5.9 Origene Technologies
5.9.1 Origene Technologies Profile
5.9.2 Origene Technologies Main Business
5.9.3 Origene Technologies Genome Editing and Genome Engineering Products, Services and Solutions
5.9.4 Origene Technologies Genome Editing and Genome Engineering Revenue (US$ Million) & (2018-2023)
5.9.5 Origene Technologies Recent Developments
5.10 Transposagen Biopharmaceuticals
5.10.1 Transposagen Biopharmaceuticals Profile
5.10.2 Transposagen Biopharmaceuticals Main Business
5.10.3 Transposagen Biopharmaceuticals Genome Editing and Genome Engineering Products, Services and Solutions
5.10.4 Transposagen Biopharmaceuticals Genome Editing and Genome Engineering Revenue (US$ Million) & (2018-2023)
5.10.5 Transposagen Biopharmaceuticals Recent Developments
5.11 Editas Medicine
5.11.1 Editas Medicine Profile
5.11.2 Editas Medicine Main Business
5.11.3 Editas Medicine Genome Editing and Genome Engineering Products, Services and Solutions
5.11.4 Editas Medicine Genome Editing and Genome Engineering Revenue (US$ Million) & (2018-2023)
5.11.5 Editas Medicine Recent Developments
5.12 Crispr Therapeutics
5.12.1 Crispr Therapeutics Profile
5.12.2 Crispr Therapeutics Main Business
5.12.3 Crispr Therapeutics Genome Editing and Genome Engineering Products, Services and Solutions
5.12.4 Crispr Therapeutics Genome Editing and Genome Engineering Revenue (US$ Million) & (2018-2023)
5.12.5 Crispr Therapeutics Recent Developments
5.13 Tecan Life Sciences
5.13.1 Tecan Life Sciences Profile
5.13.2 Tecan Life Sciences Main Business
5.13.3 Tecan Life Sciences Genome Editing and Genome Engineering Products, Services and Solutions
5.13.4 Tecan Life Sciences Genome Editing and Genome Engineering Revenue (US$ Million) & (2018-2023)
5.13.5 Tecan Life Sciences Recent Developments
6 North America
6.1 North America Genome Editing and Genome Engineering Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Genome Editing and Genome Engineering Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Genome Editing and Genome Engineering Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Genome Editing and Genome Engineering Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Genome Editing and Genome Engineering Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Genome Editing and Genome Engineering Market Dynamics
11.1 Genome Editing and Genome Engineering Industry Trends
11.2 Genome Editing and Genome Engineering Market Drivers
11.3 Genome Editing and Genome Engineering Market Challenges
11.4 Genome Editing and Genome Engineering Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List